These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. Holm LE; Lundell G; Israelsson A; Dahlqvist I J Nucl Med; 1982 Feb; 23(2):103-7. PubMed ID: 7057248 [TBL] [Abstract][Full Text] [Related]
43. [Iodine-125 in treatment of hyperthyreosis (author's transl)]. Glanzmann C; Piroth HD; Magdeburg W; Horst W Radiol Clin Biol; 1974; 43(4):344-7. PubMed ID: 4827304 [No Abstract] [Full Text] [Related]
44. [A case of chronic myelogenous leukemia with atypical clinical course seen in a radiological worker (author's transl)]. Sato I; Endo K; Mikami M; Niikawa K; Sasaki T Rinsho Ketsueki; 1977 Sep; 18(9):1143-9. PubMed ID: 271251 [No Abstract] [Full Text] [Related]
46. Iodine-131 therapy of hyperthyroidism in pediatric patients. Clark JD; Gelfand MJ; Elgazzar AH J Nucl Med; 1995 Mar; 36(3):442-5. PubMed ID: 7884506 [TBL] [Abstract][Full Text] [Related]
47. Health effects of therapeutic use of 131I in hyperthyroidism. Pauwels EK; Smit JW; Slats A; Bourguignon M; Overbeek F Q J Nucl Med; 2000 Dec; 44(4):333-9. PubMed ID: 11302261 [TBL] [Abstract][Full Text] [Related]
48. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [TBL] [Abstract][Full Text] [Related]
49. [Iodine-induced hyperthyroidism in the aged. 2. Pathomechanism, differential diagnosis and therapy problems]. Schwarzfischer P; Harlass G; Kreul HG; Schmitt M Fortschr Med; 1982 Feb; 100(5):153-8. PubMed ID: 7076085 [TBL] [Abstract][Full Text] [Related]
50. [The influence of radioiodine therapy on the content of sulphhydryl groups in blood serum in toxic struma (author's transl)]. Livergant JE; Semenov VD; Tarchanova MV Radiobiol Radiother (Berl); 1976; 17(6):691-8. PubMed ID: 1019318 [No Abstract] [Full Text] [Related]
51. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376 [TBL] [Abstract][Full Text] [Related]
52. Prompt treatment of hypothyroidism following radioiodine therapy: impact on thyroid function and mortality. Kahaly GJ Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):134-5. PubMed ID: 16932271 [No Abstract] [Full Text] [Related]
53. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
54. Thyrotoxicosis in Sierra Leone: diagnosis and treatment with radioactive iodine (131I). Knox-Macaulay HH Trop Geogr Med; 1982 Jun; 34(2):169-75. PubMed ID: 7123649 [TBL] [Abstract][Full Text] [Related]
55. [Must the high rate of hypothyroidism after radioiodine therapy for immunogenic hyperthyroidism be considered a part of the cost?]. Emrich D Nuklearmedizin; 1997 Aug; 36(5):5-6. PubMed ID: 9380532 [No Abstract] [Full Text] [Related]
56. [Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism]. Mihailović J; Malesević M; Stefanović L; Krkljus D Med Pregl; 1995; 48(11-12):412-5. PubMed ID: 8643057 [TBL] [Abstract][Full Text] [Related]